Brodimoprim

Chemical compound
  • J01EA02 (WHO)
Identifiers
  • 5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine
CAS Number
  • 56518-41-3 checkY
PubChem CID
  • 68760
ChemSpider
  • 62004 checkY
UNII
  • V1YC7T6LLI
KEGG
  • D07238 checkY
ChEBI
  • CHEBI:131726
ChEMBL
  • ChEMBL31891 checkY
CompTox Dashboard (EPA)
  • DTXSID20205070 Edit this at Wikidata
ECHA InfoCard100.054.745 Edit this at WikidataChemical and physical dataFormulaC13H15BrN4O2Molar mass339.193 g·mol−13D model (JSmol)
  • Interactive image
Melting point225 to 228 °C (437 to 442 °F)
  • Brc1c(OC)cc(cc1OC)Cc2cnc(nc2N)N
InChI
  • InChI=1S/C13H15BrN4O2/c1-19-9-4-7(5-10(20-2)11(9)14)3-8-6-17-13(16)18-12(8)15/h4-6H,3H2,1-2H3,(H4,15,16,17,18) checkY
  • Key:BFCRRLMMHNLSCP-UHFFFAOYSA-N checkY
  (verify)

Brodimoprim is a structural derivative of trimethoprim. In brodimoprim, the 4-methoxy group of trimethoprim is replaced with a bromine atom.

As trimethoprim, brodimoprim is a selective inhibitor of bacterial dihydrofolate reductase.[1]

References

  1. ^ Thomson CJ (December 1993). "Trimethoprim and brodimoprim resistance of gram-positive and gram-negative bacteria". Journal of Chemotherapy. 5 (6): 458–64. doi:10.1080/1120009X.1993.11741096. PMID 8195838.
  • v
  • t
  • e
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor
Sulfonamides
(DHPS inhibitor)
Short-acting
Intermediate-acting
Long-acting
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation
Fluoroquinolones
2nd generation
3rd generation
4th generation
Veterinary
Newer non-fluorinated
Related (DG)
Anaerobic DNA
inhibitors
Nitroimidazole derivatives
Nitrofuran derivatives
RNA synthesis
Rifamycins/
RNA polymerase
Lipiarmycins
Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e